🟢 Nautilus Biotechnology is trading 6.3% up amid a biotech-sector rally

Nautilus Biotechnology is trading at $2.71, up 6.27%, amid a biotech-sector rally; no company-specific catalyst for the October 21 move surfaced in the search.

• The supplied sector context shows XBI up 2.10%, amid M&A and positive clinical-trial news; this is not a confirmed direct catalyst for the stock.
• The prior session closed at $2.55, down 3.04%, after a 27.67% rise on October 19. October 21 trading volume was unavailable.
• The company announced its Q3 results date as October 27.